Trials / Completed
CompletedNCT01669265
Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 701 (actual)
- Sponsor
- SOLTI Breast Cancer Research Group · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a retrospective, multicentric cohort study of patient cases with cT1-3, N0 early breast cancer, who previously had intraoperative sentinel lymph node (SLN) evaluation by one-step nucleic acid amplification (OSNA) assay with a complete axillary dissection. The aim of the present study is to assess the intraoperative positive SLN total tumor load (TTL) obtained from the OSNA assay and to determine whether this TTL predicts non-SLN metastasis in patients with clinically node-negative early-stage breast cancer.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2012-06-01
- Completion
- 2012-08-01
- First posted
- 2012-08-20
- Last updated
- 2014-11-18
Locations
9 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01669265. Inclusion in this directory is not an endorsement.